Desvenlafaxine

PRISTIQ 100 mg COMPRIMIDOS DE LIBERACION PROLONGADA

151,77 mg comprimido de liberación prolongadaSpainMarketedAuthorised 29 Feb 2012

In other countries

The same active substances on other registers, the same brand first.

PristiqBrazil · Pfizer Brasil LtdaSame brand
PristiqCanada · 100 MG · Tablet (Extended-Release) · Pfizer Canada UlcSame brand
PristiqCanada · 50 MG · Tablet (Extended-Release) · Pfizer Canada UlcSame brand
Pristiq 50MG Extended Release TabletsSaudi Arabia · PfizerSame brand
Pristiq Extended-Release Tablet 50mgSingapore · 50 mg · tablet, extended release · Pfizer Private LimitedSame brand
PristiqUnited States · 100MG BASE, 25MG BASE, 50MG BASE · tablet, extended release · PF Prism CVSame brand
AG-DesvenlafaxineCanada · 50 MG · Tablet (Extended-Release) · Angita Pharma INC.Same form

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Desvenlafaxine

PRISTIQ 100 mg COMPRIMIDOS DE LIBERACION PROLONGADA

151,77 mg comprimido de liberación prolongadaSpainMarketedAuthorised 29 Feb 2012

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

FaxilexItaly · Compressa a rilascio prolungato · Neuraxpharm Italy S.P.A.

Desenda®Serbia · 50mg · tableta sa produženim oslobađanjem · Galenika Ad Beograd

DesvenlafaxineUnited States · 100MG, 50MG · tablet, extended release · Alembic Pharms LTD

Desvenlafaxine SuccinateUnited States · 100MG BASE, 25MG BASE, 50MG BASE · tablet, extended release · Zydus Pharms

AfaxBrazil · Prati Donaduzzi & Cia Ltda

AndesBrazil · Supera Farma Laboratórios S.A

PristiqsEuropean Union · Wyeth Europe Ltd.

DavlexSaudi Arabia · United International Company

Packs

Pack	Code	Status
PRISTIQ 100 mg COMPRIMIDOS DE LIBERACION PROLONGADA , 28 comprimidos	688232

Documents

The official texts, at the regulator.

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required · Added 12 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Desvenlafaxine
Strength: 151,77 mg
Dosage form: comprimido de liberación prolongada
Route: vía oral
Register: Spain (AEMPS)
Status: Marketed
Status in the register: Autorizado, comercializado
Authorised: 29 Feb 2012
Registration: 75561
Marketing authorisation holder: Pfizer S.L.
Procedure: National, MRP or DCP
Supply: Medicamento Sujeto A Prescripción Médica

Spain

PRISTIQ 50 mg COMPRIMIDOS DE LIBERACION PROLONGADADesvenlafaxine · 75,87 mg · comprimido de liberación prolongadaSpain

Enzude 100 MG Comprimidos de Liberacion ProlongadaDesvenlafaxine · 151,77 mg · comprimido de liberación prolongadaSpainWithdrawn

Enzude 50 MG Comprimidos de Liberacion ProlongadaDesvenlafaxine · 75,87 mg · comprimido de liberación prolongadaSpainWithdrawn